# Eloxx Pharmaceuticals, Inc.: Form DEF 14A, filed Oct 31, 2022

- Company: [Eloxx Pharmaceuticals, Inc.](/companies/elox.md) (CIK 1035354)
- Form: DEF 14A
- Filed: 2022-10-31
- Accepted by EDGAR: Oct 31, 2022, 20:31 ET
- Period: 2022-11-30
- Accession: 0001140361-22-039123
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1035354/000114036122039123/ny20005367x2_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1035354/000114036122039123/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1035354/000114036122039123/ny20005367x2_def14a.htm

Filed Oct 31, 2022.
Source: SEC EDGAR, the filing index for accession 0001140361-22-039123. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.